Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy
| dc.contributor.author | Smyth, P. | |
| dc.contributor.author | Ferguson, L. | |
| dc.contributor.author | Burrows, J. F. | |
| dc.contributor.author | Burden, R. E. | |
| dc.contributor.author | Tracey, S. R. | |
| dc.contributor.author | Herron, M. | |
| dc.contributor.author | Kovaleva, M. | |
| dc.contributor.author | Williams, R. | |
| dc.contributor.author | Porter, A. J. | |
| dc.contributor.author | Longley, D. B. | |
| dc.contributor.author | Barelle, C. J. | |
| dc.contributor.author | Scott, C. J. | |
| dc.contributor.institution | University of Aberdeen.Microbiology and Immunity | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.date.accessioned | 2024-01-30T11:20:00Z | |
| dc.date.available | 2024-01-30T11:20:00Z | |
| dc.date.issued | 2023-12-05 | |
| dc.description | Funding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded through a grant from the BBSRC (BB/R009112/1). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 13 | |
| dc.format.extent | 2554269 | |
| dc.identifier | 283797507 | |
| dc.identifier | 9c1d9b93-b310-4e82-8656-0c7e5135a11b | |
| dc.identifier | 85180124183 | |
| dc.identifier.citation | Smyth, P, Ferguson, L, Burrows, J F, Burden, R E, Tracey, S R, Herron, M, Kovaleva, M, Williams, R, Porter, A J, Longley, D B, Barelle, C J & Scott, C J 2023, 'Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy', Frontiers in Pharmacology, vol. 14, 1296567. https://doi.org/10.3389/fphar.2023.1296567 | en |
| dc.identifier.doi | 10.3389/fphar.2023.1296567 | |
| dc.identifier.issn | 1663-9812 | |
| dc.identifier.uri | https://hdl.handle.net/2164/22667 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85180124183&partnerID=8YFLogxK | en |
| dc.identifier.vol | 14 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Frontiers in Pharmacology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | cancer | en |
| dc.subject | cathepsin | en |
| dc.subject | inhibitor | en |
| dc.subject | therapeutic | en |
| dc.subject | vNAR | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject | Pharmacology | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject | BB/R009112/1 | en |
| dc.subject.lcc | RM | en |
| dc.title | Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Smyth_etal_FIP_Evaluation_Of_Variable_VoR.pdf
- Size:
- 2.44 MB
- Format:
- Adobe Portable Document Format
